Economy
Agreement Inked To Establish Vaccines Factory In Khazaen City Worth RO20M
Khazaen Economic City signed an agreement with Opal For Biopharmaceuticals and Business Company to establish a factory for the production of biological human vaccines to the tune of RO20mn.
The first phase of the project will be set up on a total area of 37,000 square meters.

The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal For Biopharmaceuticals and Business Company.
Al Thuhli said that this project will be the first vaccines factory in Khazaen Economic City and it targets local and international markets. The agreement, Al Thuhli added, comes as part of Khazaen’s efforts in attracting local and international investments.
-
Magazines2 months agoOER – September 2025 Issue
-
Alamaliktistaad Magazines1 month agoAlam Al Iktisaad – September 2025 Edition
-
News1 month agoKitchenomiKs Secures Investment of US$3.2M Led by Jasoor Ventures
-
News2 months agoCent Capital, AI Finance App by ex-AWS Strategist ‘The Beast of Bay Area,’ Launches to End Financial Anxiety, Hits $1M AUM
-
News2 months agoOman Inaugurates ‘Hadatha’ – Its All-New Cybersecurity Center
-
Banking & Finance1 month agoOman Arab Bank Highlights Its Ongoing Strategic Initiatives and Future Plans
-
News1 month agoIEA Expects Global Oil Market to Remain Oversupplied in 2026
-
Energy1 month agoWLGA Middle East LPG Summit & Expo 2025 to be held at OCEC on November 10 and 11
